Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
The National Zoological Park (NZP), New Delhi has launched the "NZP Saathi App" and Self-ticketing…
India's consumer grievance redressal system has achieved the milestone with the e-Jagriti platform received the…
The sate of West Bengal set to become the 36th State/Union Territory t implement the…
As per the SIPRI Yearbook 2026 India has expanded the its nuclear arsenal to an…
India's Andaman and Nicobar Islands have emerged as the region with lowest fertility rate in…
Every year on 8th of June World Oceans Day observed worldwide. This day raise the…